Explanation of Revisions

Attachment 11. Explanation of Revisions

National HIV Prevention Program Monitoring and Evaluation Data

OMB No. 0920-0696 (Expiration 2/28/2019)

On May 25, 2018, CDC received OMB approval for a non-substantive revision to the National HIV Prevention Program Monitoring and Evaluation Data Variable Set (OMB No. 0920-0696, Expiration 2/28/2019).

CDC is requesting the following revisions to adjust the variables from the most recently approved change request (May 25, 2018) in the following ways:

• Remove 48 health department budget allocation variables associated with the previous health department funding announcement PS12-1201. (Attachment 5C)

• Add 83 health department budget reporting variables. Health departments will be required to annually estimate the percentage of their overall funding allocated and expended for 11 required core strategies and activities associated with the new integrated program and surveillance health department funding awarded in January 2018 (PS18-1802). Although this represents an increase of 35 budget related variables, we anticipate no additional data collection burden since it is likely these data are already being collected by health departments and we are requesting estimated percentages rather than dollar figures annually. (Attachment 5A and Attachment 5B)

• Remove 13 of the 15 system-level variables associated with the schema for those health departments that upload data into EvaluationWeb. These variables are no longer needed for data upload to EvaluationWeb. (Attachment 5C)

• In response to stakeholder feedback, we added one additional variable to further ascertain priority populations (sex with a transgender person). (Attachment 5A and Attachment 5B)

National HIV Prevention Program Monitoring and Evaluations (NHM&E) (OMB 0920-0696, Exp. 2/2018)

Variables Added (N=84)

	Variable Number	Variable Name	Variable Definition
1	BASTRAT10a1P	Percent Allocated - Monitoring and Evaluation - Prevention	Strategy 10: Percent of PS18-1802 funding allocated for HIV Prevention developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
2	BASTRAT10a1S	Percent Allocated - Monitoring and Evaluation - Surveillance	Strategy 10: Percent of PS18-1802 funding allocated for HIV Surveillance developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
3	BASTRAT11a1P	Percent Allocated - Capacity Building and TA - Prevention	Strategy 10: Percent of PS18-1802 funding allocated for HIV Prevention developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
4	BASTRAT11a1S	Percent Allocated - Capacity Building and TA - Surveillance	Strategy 10: Percent of PS18-1802 funding allocated for HIV Surveillance developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
5	BASTRAT11a2P	Percent Allocated - Geocoding - Prevention	Strategy 10: Percent of PS18-1802 funding allocated for HIV Prevention developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
6	BASTRAT11a2S	Percent Allocated - Geocoding - Surveillance	Strategy 10: Percent of PS18-1802 funding allocated for HIV Surveillance developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
7	BASTRAT1a1S	Percent Allocated – Data Activities - Surveillance	Strategy 1: Percent of PS18-1802 funding allocated for HIV Surveillance data collection, analysis, and dissemination activities.
8	BASTRAT1a2P	Percent Allocated – Data Activities - Prevention	Strategy 1: Percent of PS18-1802 funding allocated for HIV Prevention data collection, analysis, and dissemination activities.
9	BASTRAT2a1P	Percent allocated - Routine HIV testing, Healthcare -Prevention	Strategy 2: Percent of PS18-1802 funding allocated for HIV Prevention routine opt-out HIV testing in healthcare settings.
10	BASTRAT2a2P	Percent allocated - Targeted HIV testing, non-Healthcare - Prevention	Strategy 2: Percent of PS18-1802 funding allocated for HIV Prevention targeted HIV testing in non-healthcare settings.
11	BASTRAT2a3P	Percent allocated - HIV Partner Services - Prevention	Strategy 3: Percent of PS18-1802 funding allocated for HIV Prevention HIV Partner Services.
12	BASTRAT2a4P	Percent allocated - D2C - Prevention	Strategy 3: Percent of PS18-1802 funding allocated for HIV Prevention Data-to-Care (D2C) Activities.
13	BASTRAT2a4S	Percent expended - D2C - Surveillance	Strategy 3: Percent of PS18-1802 funding allocated for HIV Surveillance Data-to-Care (D2C) Activities.
14	BASTRAT3a1P	Percent Allocated - HIV Transmission Clusters and Outbreaks - Prevention	Strategy 3: Percent of PS18-1802 funding allocated for HIV Prevention rapidly respond to and intervene in HIV transmission clusters and outbreaks.
15	BASTRAT3a1S	Percent Allocated - HIV Transmission Clusters and Outbreaks - Surveillance	Strategy 3: Percent of PS18-1802 funding allocated for HIV Surveillance rapidly respond to and intervene in HIV transmission clusters and outbreaks.
16	BASTRAT4a1P	Percent Allocated - CPP, Continuum of Care - Prevention	Strategy 4: Percent of PS18-1802 funding allocated for HIV Prevention Continuum of care - (linkage to HIV medical care, re-engagement, and retention in care).
17	BASTRAT4a2P	Percent Allocated - CPP, Risk Reduction Interventions - Prevention	Strategy 4: Percent of PS18-1802 funding allocated for risk-reduction interventions for HIV-positive persons.
18	BASTRAT4a3P	Percent Allocated - Other CPP - Prevention	Strategy 4: Percent of PS18-1802 funding allocated for other CPP activities (health benefits navigation and enrollment, referrals to behavioral health services, and social services).
19	BASTRAT5a1P	Percent Allocated - Prevention with HIV-negative persons - Prevention	Strategy 5: Percent of PS18-1802 funding allocated for HIV Prevention HIV testing and risk screenings, conduct risk reduction interventions for HIV-negative persons, health benefits navigation and enrollment, referrals to behavioral health services, and social services.
20	BASTRAT5a2P	Percent Allocated - PrEP Access and Support - Prevention	Strategy 5: Percent of PS18-1802 funding allocated for HIV Prevention PrEP access and support.
21	BASTRAT5a3P	Percent Allocated - PEP Access and Support - Prevention	Strategy 5: Percent of PS18-1802 funding allocated for HIV Prevention PEP access and support.
22	BASTRAT6a1P	Percent Allocated - Perinatal HIV Exposure Reporting - Prevention	Strategy 5: Percent of PS18-1802 funding allocated for HIV Prevention HIV testing and risk screenings, conduct risk reduction interventions for HIV-negative persons, health benefits navigation and enrollment, referrals to behavioral health services, and social services.
23	BASTRAT6a1S	Percent Allocated - Perinatal HIV Exposure Reporting - Surveillance	Strategy 5: Percent of PS18-1802 funding allocated for HIV Prevention PrEP access and support.
24	BASTRAT6a2P	Percent Allocated - Perinatal HIV Surveillance Coordination - Prevention	Strategy 5: Percent of PS18-1802 funding allocated for HIV Prevention PEP access and support.
25	BASTRAT6a2S	Percent Allocated - Perinatal HIV Surveillance Coordination - Surveillance	Strategy 6: Percent of PS18-1802 funding allocated for HIV Surveillance perinatal HIV service coordination (i.e., fetal and infant mortality review).
26	BASTRAT7a1P	Percent Allocated - Community-level Prevention Activities - Prevention	Strategy 7: Percent of PS18-1802 funding allocated for HIV Prevention social marketing campaigns, social media strategies, and community mobilization (if conducted).
27	BASTRAT7a2P	Percent Allocated - SSP - Prevention	Strategy 7: Percent of PS18-1802 funding allocated for HIV Prevention syringe services program (if conducted).
28	BASTRAT7a3P	Percent Allocated - Condom Distribution - Prevention	Strategy 7: Percent of PS18-1802 funding allocated for HIV Prevention condom distribution.
29	BASTRAT8a1P	Percent Allocated - HIV Planning - Prevention	Strategy 3: Percent of PS18-1802 funding allocated for HIV Prevention rapidly respond to and intervene in HIV transmission clusters and outbreaks.
30	BASTRAT8a1S	Percent Allocated - HIV Planning - Surveillance	Strategy 3: Percent of PS18-1802 funding expended for HIV Prevention rapidly respond to and intervene in HIV transmission clusters and outbreaks.
31	BASTRAT9a1P	Percent Allocated - Health Information Infrastructure - Prevention	Strategy 9: Percent of PS18-1802 funding allocated for HIV Prevention health information infrastructure.
32	BASTRAT9a1S	Percent Allocated - Health Information Infrastructure -Surveillance	Strategy 9: Percent of PS18-1802 funding allocated for HIV Surveillance health information infrastructure.
33	BASTRAT9a2P	Percent Allocated - Data Security and Confidentiality - Prevention	Strategy 9: Percent of PS18-1802 funding allocated for HIV Prevention data security and confidentiality.
34	BASTRAT9a2S	Percent Allocated - Data Security and Confidentiality - Surveillance	Strategy 9: Percent of PS18-1802 funding allocated for HIV Surveillance data security and confidentiality.
35	BASTRAT9a3P	Percent Allocated - Policies and Protocols - Prevention	Strategy 9: Percent of PS18-1802 funding allocated for HIV Prevention strengthen policies and protocols to support HIV surveillance and prevention at the state and local level.
36	BASTRAT9a3S	Percent Allocated - Policies and Protocols - Surveillance	Strategy 9: Percent of PS18-1802 funding allocated for HIV Surveillance strengthen policies and protocols to support HIV surveillance and prevention at the state and local level.
37	BESTRAT10a1P	Percent Expended - Monitoring and Evaluation - Prevention	Strategy 10: Percent of PS18-1802 funding expended for HIV Prevention developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
38	BESTRAT10a1S	Percent Expended - Monitoring and Evaluation - Surveillance	Strategy 10: Percent of PS18-1802 funding expended for HIV Surveillance developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
39	BESTRAT11a1P	Percent Expended - Capacity Building and TA - Prevention	Strategy 10: Percent of PS18-1802 funding expended for HIV Prevention developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
40	BESTRAT11a1S	Percent Expended - Capacity Building and TA - Surveillance	Strategy 10: Percent of PS18-1802 funding expended for HIV Surveillance developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
41	BESTRAT11a2P	Percent Expended - Geocoding - Prevention	Strategy 10: Percent of PS18-1802 funding expended for HIV Prevention developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
42	BESTRAT11a2S	Percent Expended - Geocoding - Surveillance	Strategy 10: Percent of PS18-1802 funding expended for HIV Surveillance developing work plans, ensure data quality, monitor Integrated HIV Prevention and Care Plan and Jurisdictional Epidemiological Profiles.
43	BESTRAT1a1S	Percent Expended – Data Activities - Surveillance	Strategy 1: Percent of PS18-1802 funding expended HIV Surveillance data collection, analysis, and dissemination activities.
44	BESTRAT1a2P	Percent expended - NHME	Strategy 1: Percent of PS18-1802 funding expended HIV Prevention data collection, analysis, and dissemination activities.
45	BESTRAT2a1P	Percent expended - Routine HIV testing, Healthcare - Prevention	Strategy 2: Percent of PS18-1802 funding expended for HIV Prevention routine opt-out HIV testing in healthcare settings.
46	BESTRAT2a2P	Percent expended - Targeted HIV testing, non-Healthcare - Prevention	Strategy 2: Percent of PS18-1802 funding expended for HIV Prevention targeted HIV testing in non-healthcare settings.
47	BESTRAT2a3P	Percent expended - HIV Partner Services - Prevention	Strategy 3: Percent of PS18-1802 funding expended for HIV Prevention HIV Partner Services.
48	BESTRAT2a4P	Percent expended - D2C - Prevention	Strategy 3: Percent of PS18-1802 funding expended for HIV Prevention Data-to-Care (D2C) Activities.
49	BESTRAT2a4S	Percent expended - D2C - Surveillance	Strategy 3: Percent of PS18-1802 funding expended for HIV Surveillance Data-to-Care (D2C) Activities.
50	BESTRAT3a1P	Percent Expended - HIV Transmission Clusters and Outbreaks - Prevention	Strategy 3: Percent of PS18-1802 funding expended for HIV Prevention rapidly respond to and intervene in HIV transmission clusters and outbreaks.
51	BESTRAT3a1S	Percent Expended - HIV Transmission Clusters and Outbreaks - Surveillance	Strategy 3: Percent of PS18-1802 funding expended for HIV Surveillance rapidly respond to and intervene in HIV transmission clusters and outbreaks.
52	BESTRAT4a1P	Percent Expended - CPP, Continuum of Care - Prevention	Strategy 4: Percent of PS18-1802 funding expended for HIV Prevention Continuum of care - (linkage to HIV medical care, re-engagement, and retention in care).
53	BESTRAT4a2P	Percent Expended - CPP, Risk Reduction Interventions - Prevention	Strategy 4: Percent of PS18-1802 funding expended for risk-reduction interventions for HIV-positive persons.
54	BESTRAT4a3P	Percent Expended - Other CPP - Prevention	Strategy 4: Percent of PS18-1802 funding expended for other CPP activities (health benefits navigation and enrollment, referrals to behavioral health services, and social services).
55	BESTRAT5a1P	Percent Expended - Prevention with HIV-negative persons - Prevention	Strategy 5: Percent of PS18-1802 funding expended for HIV Prevention for HIV testing and risk screenings, conduct risk reduction interventions for HIV-negative persons, health benefits navigation and enrollment, referrals to behavioral health services, and social services.
56	BESTRAT5a2P	Percent Expended - PrEP Access and Support - Prevention	Strategy 5: Percent of PS18-1802 funding expended for HIV Prevention PrEP access and support.
57	BESTRAT5a3P	Percent Expended - PEP Access and Support - Prevention	Strategy 5: Percent of PS18-1802 funding expended for HIV Prevention PEP access and support.
58	BESTRAT6a1P	Percent Expended - Perinatal HIV Exposure Reporting - Prevention	Strategy 5: Percent of PS18-1802 funding expended for HIV Prevention for HIV testing and risk screenings, conduct risk reduction interventions for HIV-negative persons, health benefits navigation and enrollment, referrals to behavioral health services, and social services.
59	BESTRAT6a1S	Percent Expended - Perinatal HIV Exposure Reporting - Surveillance	Strategy 5: Percent of PS18-1802 funding expended for HIV Prevention PrEP access and support.
60	BESTRAT6a2P	Percent Expended - Perinatal HIV Surveillance Coordination - Prevention	Strategy 5: Percent of PS18-1802 funding expended for HIV Prevention PEP access and support.
61	BESTRAT6a2S	Percent Expended - Perinatal HIV Surveillance Coordination - Surveillance	Strategy 6: Percent of PS18-1802 funding expended for HIV Surveillance perinatal HIV service coordination (i.e., fetal and infant mortality review).
62	BESTRAT7a1P	Percent Expended - Community-level Prevention Activities - Prevention	Strategy 7: Percent of PS18-1802 funding expended for HIV Prevention social marketing campaigns, social media strategies, and community mobilization (if conducted).
63	BESTRAT7a2P	Percent Expended - SSP - Prevention	Strategy 7: Percent of PS18-1802 funding expended for HIV Prevention syringe services program (if conducted).
64	BESTRAT7a3P	Percent Expended - Condom Distribution - Prevention	Strategy 7: Percent of PS18-1802 funding expended for HIV Prevention condom distribution.
65	BESTRAT8a1P	Percent Expended - HIV Planning - Prevention	Strategy 3: Percent of PS18-1802 funding allocated for HIV Surveillance rapidly respond to and intervene in HIV transmission clusters and outbreaks.
66	BESTRAT8a1S	Percent Expended - HIV Planning - Surveillance	Strategy 3: Percent of PS18-1802 funding expended for HIV Surveillance rapidly respond to and intervene in HIV transmission clusters and outbreaks.
67	BESTRAT9a1P	Percent Expended - Health Information Infrastructure - Prevention	Strategy 9: Percent of PS18-1802 funding expended for HIV Prevention health information infrastructure.
68	BESTRAT9a1S	Percent Expended - Health Information Infrastructure - Surveillance	Strategy 9: Percent of PS18-1802 funding expended for HIV Surveillance health information infrastructure.
69	BESTRAT9a2P	Percent Expended - Data Security and Confidentiality - Prevention	Strategy 9: Percent of PS18-1802 funding expended for HIV Prevention data security and confidentiality.
70	BESTRAT9a2S	Percent Expended - Data Security and Confidentiality - Surveillance	Strategy 9: Percent of PS18-1802 funding expended for HIV Surveillance data security and confidentiality.
71	BESTRAT9a3P	Percent Expended - Policies and Protocols - Prevention	Strategy 9: Percent of PS18-1802 funding expended for HIV Prevention strengthen policies and protocols to support HIV surveillance and prevention at the state and local level.
72	BESTRAT9a3S	Percent Expended - Policies and Protocols - Surveillance	Strategy 9: Percent of PS18-1802 funding expended for HIV Surveillance strengthen policies and protocols to support HIV surveillance and prevention at the state and local level.
73	CSTRATEGY1	Comments - Strategy 1	Jurisdiction comments for Strategy 1, Data collection, analysis, and dissemination of HIV data.
74	CSTRATEGY10	Comments - Strategy 10	Jurisdiction comments for Strategy 10, Monitoring and Evaluation to improve HIV surveillance, prevention, and care activities
75	CSTRATEGY11	Comments - Strategy 11	Jurisdiction comments for Strategy 11, Capacity Building and Technical Assistance.
76	CSTRATEGY2	Comments - Strategy 2	Jurisdiction comments for Strategy 2, Identify persons with HIV infection and uninfected persons at risk for HIV infection, HIV testing in non-healthcare settings.
77	CSTRATEGY3	Comments - Strategy 3	Jurisdiction comments for Strategy 3, Develop, maintain, and implement plan to respond to HIV transmission clusters and outbreaks.
78	CSTRATEGY4	Comments - Strategy 4	Jurisdiction comments for Strategy 4, Comprehensive prevention with positives (CPP).
79	CSTRATEGY5	Comments - Strategy 5	Jurisdiction comments for Strategy 5, Comprehensive prevention with HIV-negative persons at risk for HIV infection.
80	CSTRATEGY6	Comments - Strategy 6	Jurisdiction comments for Strategy 6, Perinatal HIV Prevention and Surveillance.
81	CSTRATEGY7	Comments - Strategy 7	Jurisdiction comments for Strategy 7, Community-level HIV prevention activities.
82	CSTRATEGY8	Comments - Strategy 8	Jurisdiction comments for Strategy 8, Integrated HIV Prevention and Care Planning.
83	CSTRATEGY9	Comments - Strategy 9	Jurisdiction comments for Strategy 9, Strengthen policies and protocols to support HIV surveillance and prevention at the state and local level.
84	G403	Sex with a transgender person	The client/patient self-reported having sex with a transgender person in the past 5 years.

National HIV Prevention Program Monitoring and Evaluations (NHM&E) (OMB 0920-0696, Exp. 2/2018)

Variables No Longer Required (N=61, 48 budget variables and 13 XML variables)

	Variable Number	Variable Name	Variable Definition
1	BT100a	Budget allocation reporting year	Budget allocation reporting year refers to the 12-month calendar year (January-December) for which the budget allocation is being reported.
2	BT101a	Amount of PS12-1201 Category A funds allocated for HIV testing in healthcare settings	For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value represents the allocation associated with HIV testing in healthcare settings. HIV testing in healthcare settings is a testing strategy that involves testing person
3	BT102a	Amount of PS12-1201 Category A funds allocated for HIV testing in non-healthcare settings	For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value represents the allocation associated with HIV testing in non-healthcare settings. HIV testing in non-healthcare settings is a testing strategy that involves testin
4	BT102m	Open-ended question 2 for HIV testing in non-healthcare settings	Please provide any additional information to explain funding allocation limitations or caveats for HIV testing in non-healthcare settings that may be a concern to you, if applicable.
5	BT103a	Amount of PS12-1201 Category A funds allocated for comprehensive prevention with positives	For PS12-1201 Category A award (HIV Prevention Programs for Health Departments); this value represents the funding allocation associated with comprehensive prevention with positives (CPP) programs and services. CPP covers a range of prevention activities
6	BT103i	Open-ended question 1 for comprehensive prevention with positives	Please identify the specific prevention activities included in the allocations to “other CPP” activities category.
7	BT103k	Amount of PS12-1201 Category A funding allocated for partner services	For PS12-1201 Category A, this value represents the allocation associated with Partner Services.
8	BT103n	Amount of PS12-1201 Category A funding allocated for HIV continuum of care which includes linkage, retention, and re-engagement in care, and HIV medication adherence support	For PS12-1201 Category A, this value represents the allocation associated with HIV continuum of care which includes linkage, retention, and re-engagement in care, and HIV medication adherence support.
9	BT103q	Amount of PS12-1201 Category A funding allocated for risk-reduction EBIs with HIV-positive persons	For PS12-1201 Category A, this value represents the allocation associated with risk-reduction EBIs with HIV-positive persons.
10	BT103t	Amount of PS12-1201 Category A funding allocated for other comprehensive prevention activities with HIV-positive persons	For PS12-1201 Category A, this value represents the allocation associated with other comprehensive prevention activities with HIV-positive persons.
11	BT104a	Amount of PS12-1201 Category A funding allocated for condom distribution	For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value represents the funding allocation associated with condom distribution.
12	BT104g	Open-ended question 2 for condom distribution	Please provide any additional information to explain condom distribution-related funding allocation limitations or caveats that may be a concern to you, if applicable.
13	BT105a	Amount of PS12-1201 Category A allocated for Policy Initiatives	For PS12-1201 Category A award (HIV Prevention Programs for Health Departments), this value represents the allocation associated with policy initiatives.
14	BT106g	Amount of PS12-1201 Category A funding allocated for other components	For PS12-1201 Category A, this value represents the allocation associated with other non-required prevention activities, excluding support services.
15	BT106h	Open-ended question for PS12-1201 Category A funds allocated for other components	If you have allocated PS12-1201 Category A funds to other components, please list the program or activities that you are going to implement or have implemented.
16	BT107c	Amount of PS12-1201 Category A funds allocated for HIV prevention program monitoring and evaluation	For PS12-1201 Category A, this value represents the allocation associated with program monitoring and evaluation.
17	BT108c	Amount of PS12-1201 Cateogry A funds allocated for Jurisdictional HIV Prevention Planning	For PS12-1201 Category A, this value represents the allocation associated with jurisdictional HIV prevention planning.
18	BT109c	Amount of PS12-1201 Category A funds allocated for Capacity Building and Technical Assistance	For PS12-1201 Category A, this value represents the allocation associated with capacity building and technical assistance
19	BT110c	Amount of PS12-1201 Category A funds allocated for agency's general operations or admin activities	For PS12-1201 Category A, this value represents the allocation associated with agency's general operations or administrative activities.
20	BT111	Open-ended question for overall budget allocation	Please provide any additional information to explain funding allocation limitations or caveats that may be a concern to you, if applicable, for any of the budget allocation variables.
21	BT101b	Amount of PS12-1201 Category B funds allocated for HIV testing in healthcare settings	For PS12-1201 Category B award (Expanded HIV Testing for Disproportionately Affected Populations), this value represents the allocation associated with HIV testing in healthcare settings performed using Category B funds.
22	BT101c	Amount of PS12-1201 Category C funds allocated for HIV testing in healthcare settings	For PS12-1201 Category C award (Demonstration Projects), this value represents the funds allocated from your Category C award that are for HIV testing in healthcare settings.
23	BT102b	Amount of PS12-1201 Category B funds allocated for HIV testing in non-healthcare settings	For PS12-1201 Category B award (Expanded HIV Testing for Disproportionately Affected Populations), this value represents the allocation associated with HIV testing in non-healthcare settings.
24	BT102c	Amount of PS12-1201 Category C funds allocated for HIV testing in non-healthcare settings	For PS12-1201 Category C award (Demonstration Projects), this value represents the allocation associated with HIV testing in non-healthcare settings.
25	BT103b	Amount of PS12-1201 Category B funds allocated for comprehensive prevention with positives	For PS12-1201 Category B award (Expanded HIV Testing for Disproportionately Affected Populations); this value represents the funding allocation associated with comprehensive prevention with positives (CPP) programs and services.
26	BT103c	Amount of PS12-1201 Category C funds allocated for comprehensive prevention with positives	For PS12-1201 Category C award (Demonstration Projects); this value represents the funding allocation associated with comprehensive prevention with positives (CPP) programs and services.
27	BT103l	Amount of PS12-1201 Category B funding allocated for partner services	For PS12-1201 Category B, this value represents the allocation associated with Partner Services.
28	BT103m	Amount of PS12-1201 Category C funding allocated for partner services	For PS12-1201 Category C, this value represents the allocation associated with Partner Services.
29	BT103o	Amount of PS12-1201 Category B funding allocated for HIV continuum of care which includes linkage, retention, and re-engagement in care, and HIV medication adherence support.	For PS12-1201 Category B, this value represents the allocation associated with HIV continuum of care which includes, linkage, retention, and re-engagement in care, and HIV medication adherence support.
30	BT103p	Amount of PS12-1201 Category C funding allocated for HIV continuum of care which includes linkage, retention, and re-engagement in care, and HIV medication adherence support	For PS12-1201 Category C, this value represents the allocation associated with HIV continuum of care which includes linkage, retention, and re-engagement in care, and HIV medication adherence support.
31	BT103r	Amount of PS12-1201 Category B funding allocated for risk-reduction EBIs with HIV-positive persons	For PS12-1201 Category B, this value represents the allocation associated with risk-reduction EBIs with HIV-positive persons.
32	BT103s	Amount of PS12-1201 Category C funding allocated for risk-reduction EBIs with HIV-positive persons	For PS12-1201 Category C, this value represents the allocation associated with risk-reduction EBIs for HIV-positive persons.
33	BT103u	Amount of PS12-1201 Category B funding allocated for other comprehensive prevention activities with HIV-positive persons	For PS12-1201 Category B, this value represents the allocation associated with other comprehensive prevention activities with HIV-positive persons.
34	BT103v	Amount of PS12-1201 Category C funding allocated for other comprehensive prevention activities with HIV-positive persons	For PS2-1201 Category C, this value represents the allocation associated with other comprehensive activities with HIV-positive persons.
35	BT104h	Amount of PS12-1201 Category C funding allocated for condom distribution	For PS12-1201 Category C, this value represents the allocation associated with condom distribution.
36	BT104i	Amount of PS12-1201 Category B funding allocated for condom distribution	For PS12-1201 Category B, this value represents the allocation associated with condom distribution.
37	BT106b	Amount of PS12-1201 Category B allocated for service integration (optional)	For PS12-1201Category B award (Expanded HIV Testing for Disproportionately Affected Populations), this value represents the allocation associated with the optional services integration component.
38	BT106e	Open-ended question for PS12-1201 Category B funds allocated for service integration	If you have allocated PS12-1201 Category B funds to other components, please list the programs or activities that you are going to implement or have implemented.
39	BT106i	Amount of PS12-1201 Category B funding allocated for other components	For PS12-1201 Category B, this value represents the allocation associated with other non-required prevention activities excluding service integration and support services.
40	BT106j	Amount of PS12-1201 Category C funding allocated for other components	For PS12-1201 Category C, this value represents the allocation associated with other non-required prevention activities excluding support services.
41	BT106k	Open-ended question for PS12-1201 Category B funds allocated for recommended and other components	If you have allocated PS12-1201 Category B funds to other components, please list the program or activities that you are going to implement or have implemented.
42	BT106l	Open-ended question for PS12-1201 Category C funds allocated for recommended and other components	If you have allocated PS12-1201 Category C funds ot other components, please list the program or activities that you are going to implement or have implemented.
43	BT107d	Amount of PS12-1201 Category B funds alloacted for HIV prevention program monitoring and evaluation	For PS12-1201 Category B, this value represents the allocation associated with program monitoring and evaluation.
44	BT107e	Amount of PS12-1201 Category C funds allocated for HIV prevention program monitoring and evaluation	For PS12-1201 Category C, this value represents the allocation associated with program monitoring and evaluation.
45	BT109d	Amount of PS12-1201 Category B funds allocated for Capacity Building, Technical Assistance, and systems for third party reimbursement for HIV testing and and other related co-infections	For PS12-1201 Category B, this value represents the allocation associated with capacity building, technical assistance, and systems for third party reimbursement for HIV testing and other related co-infections.
46	BT109e	Amount of PS12-1201 Category C funds allocated for Capacity Building and Technical Assistance	For PS12-1201 Category C, this value represents the allocation associated with capacity building and technical assistance.
47	BT110d	Amount of PS12-1201 Category B funds allocated for agency's general operations or admin activities	For PS12-1201 Category B, this value represents the allocation associated with agency's general operations or administrative activities.
48	BT110e	Amount of PS12-1201 Category C funds allocated for agency's general operations or admin activities	For PS12-1201 Category C, this value represents the allocation associated with agency's general operations or administrative activities.
49	Z01	Status	The indicator to define the status of the record. This status indicator is used by a number of different records (Site, HivForm, aggregateData. Etc.). This indicator is always an attribute (for example <HivForm status=”N”>…). Check the relevant XSD to d
50	Z02	Last Modified Date	An indicator to denote the date on which the record was modified based on the last time the record was modified This indicator is always an attribute in the XML. (<HivForm lastModifiedDate=”01/01/2013”>). See the relevant XSD to determine which elements
51	Z03a	CT Schema Version Number	Specifies the version of the XSD which has been used to validate the XML file.
52	Z03b	PS Schema Version Number	Specifies the version of the XSD which has been used to validate the XML file.
53	Z04	Agency ID Sending File	The agency which sent the XML data file. This field allows for better CDC management of multiple files from multiple entities.
54	Z05a	First Date of Data Included in File	Specifies the first date of data included in the file and allows for better data management (duplicate identification). This helps to identify the correct data receiving process necessary to handle the XML message.
55	Z05b	Last Date of Data Included in File	Specifies the last date of data included in the file and allows for better data management (duplicate identification). This helps to identify the correct data receiving process necessary to handle the XML message.
56	Z07	Contact Person Information	Contact information of the person who manages the packaging and sending of the data.
57	Z08	Collection of Agency IDs Included in File	The IDs of each agency for which data are being transmitted in the file.
58	Z09	Date File Was Created	The date (and optionally, the time) the XML file was created.
59	Z10	Date File Last Modified	If the file has been modified, the date (and optionally, the time) the XML file was last modified.
60	Z11	Special Instructions	Special instructions about XML file, if any.
61	Z12	Agency Name of Data Owner	The actual agency owner of the submitted XML file.

19